LB Pharmaceuticals


LB Pharmaceuticals is a drug development company focused on development treatments for CNS disorders. The company's lead compound is LB-102; a novel benzamide being developed the treatment of schizophrenia owned and development internally by LB. LB-102 recently completed a Phase 1 study; a First-in-... Read more

Industries

Employees

1-10

Links


Org chart

Collapse
Andrew Vaino
Chief Scientific Officer
Marc Panoff
Chief Financial Officer
Anna Eramo
Chief Medical Officer

Board & advisors

Robert Ruffolo
Board Director
Ira D. Glick
Scientific Advisor
John M. Kane
Scientific Advisor
Herbert Y. Meltzer
Scientific Advisor
Stefan Leucht
Scientific Advisor
Christoph U. Correll
Scientific Advisor

Teams

This company has no teams yet


Offices